Steven Walter Children’s
One simple goal. 100% survival for all children diagnosed
Tackling the toughest cancers.
Neuroblastoma, almost exclusively occurs in children aged 0-5 years and has poor survival rates. Our funding, along with SWCCF provides access for approximately 180 children to leading international neuroblastoma clinical trials offering optimised treatments. The trials are a major step forward to finding a cure for this particularly aggressive disease.